SURMOUNT-5 Head-to-Head In 2025, Eli Lilly published the SURMOUNT-5 trial directly comparing tirzepatide (15 mg) and semaglutide (2.4 mg) in adults with obesity over 72 weeks
Heres how it helps: Insulin Production When you eat, GLP-1 helps your body produce more insulin
Have they been clinically tested to work
Furthermore, alongside the increasing prevalence of related cardiometabolic diseases such as diabetes, obesity and chronic kidney disease (CKD), the number of people with HF has increased to around 64 million globally, amongst whom most are also living with type 2 diabetes or obesity (Groenewegen et al., 2020)
$224/mo tirzepatide 6-month estimate: $600 semaglutide / $1,100 tirzepatide (promo pricing shown) Insurance: Yes Self-pay: Yes Clinical Features Lab testing: Yes Dietitian access: Yes Verified Pharmacy: FDA-inspected, state-regulated 503A/503B compounding pharmacies
Critical Note: Even though Type 1 implies insulin use, Z79.4 is still appropriate under current ICD-10-CM guidelines when documentation supports ongoing insulin use